News
One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...
FDA Drug Inspections Post–Workforce Reductions: Potential Implications and Practical Steps Forward
The US Food and Drug Administration (FDA) is confronted with significant challenges in its inspection processes due to recent layoffs. Among ...
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...
Current employees say that dramatic cuts to leadership and career staff within FDA and HHS have left critical projects at risk.
As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.
Canadian health experts warn the fallout from thousands of job cuts at the U.S. Food and Drug Administration on April 1 could ...
The Trump administration’s remaking of HHS — in a matter of weeks — is sparking basic questions about how parts of the agency ...
Far as he was from Washington, D.C., as Health and Human Services Secretary Robert F. Kennedy Jr. hiked to the top of a ...
WASHINGTON (AP) — Weeks after ordering all Food and Drug Administration employees back into the office, the agency is ...
Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...
Layoffs at the Food and Drug Administration are expected to reduce the FDA's workforce by 20%. Susan Mayne, former director ...
The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was responsible for a host of activities that were central to ensuring generic drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results